RecruitingNot ApplicableNCT04867187

rTMS Efficacy Coupled With Mirror Therapy

Clinical Study of Repetitive Transcranial Magnetic Stimulation (RTMS) Efficacy Coupled With Mirror Therapy for Neuropathic Pain Relief


Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

64 participants

Start Date

Oct 27, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Neuropathic pain is particularly difficult to treat with classic first-line drugs. Neuromodulation techniques using repetitive transcranial magnetic stimulation (rTMS) are useful alternative, but there is a need to improve their analgesic effect.Virtual reality mirror therapy has shown the capacity to alleviate pain and may be easily coupled with rTMS.The present project will investigate in individuals with neuropathic pain the effects of the rTMS coupled with virtual reality mirror therapy.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Mirror therapy using sham mirror, Mirror therapy using virtual reality, and others for people with neuropathic pain. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRepetitive transcranial magnetic stimulation (rTMS)

20 minutes of high frequency (20Hz) rTMS.

OTHERMirror therapy using virtual reality

active mirror-based therapy

OTHERMirror therapy using sham mirror

20 minutes of sham mirror-based therapy


Locations(2)

Hôpital Neurologique Pierre Wertheimer

Bron, France

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04867187


Related Trials